Baseline Laboratory Testing for a 47-Year-Old Male with No Medical History
For a 47-year-old man presenting for routine follow-up with no documented medical history, order: fasting lipid profile, fasting glucose (or HbA1c), complete blood count, comprehensive metabolic panel (electrolytes, creatinine, liver function tests), thyroid-stimulating hormone, and urinalysis.
Core Laboratory Panel
The most comprehensive guidance comes from the ACC/AHA heart failure guidelines 1, which recommend initial laboratory evaluation including:
- Complete blood count – screens for anemia and hematologic abnormalities
- Serum electrolytes (including calcium and magnesium)
- Blood urea nitrogen and serum creatinine – assesses kidney function
- Fasting blood glucose (or glycohemoglobin/HbA1c)
- Lipid profile – critical for cardiovascular risk assessment
- Liver function tests
- Thyroid-stimulating hormone
- Urinalysis
While these guidelines target heart failure patients, they establish a comprehensive baseline assessment framework applicable to general health evaluation 1.
Age-Specific Considerations at 47 Years
Lipid Screening
Lipid screening is mandatory at this age. The lipid profile has the highest therapeutic yield (16.5%) of all routine laboratory tests 2. Men aged 40-75 years should undergo lipid screening as standard practice 3.
Glucose Testing
Fasting glucose or HbA1c is essential for diabetes screening. This becomes increasingly important in middle age, with preventive screenings revealing substantial undiagnosed conditions 4.
Prostate Cancer Screening Discussion
At 47, this patient approaches the age for prostate cancer screening discussions. However, PSA testing requires shared decision-making and should not be ordered without informed consent 5, 6, 7. The NCCN guidelines recommend baseline PSA at age 40 for men opting into screening programs, with annual follow-up if PSA ≥1.0 ng/mL 5. The ACS recommends beginning informed decision-making discussions at age 50 for average-risk men, or age 45 for African American men or those with first-degree relatives diagnosed before age 65 6, 7.
Do not order PSA without first discussing risks, benefits, and uncertainties with the patient.
Tests with Lower Yield
The therapeutic yield varies significantly:
- Chemistry panel: 2.8%
- Complete blood count: 0.9%
- Urinalysis: 0.8%
- Thyroid tests: 0.7%
Despite lower individual yields, these tests collectively identify important conditions 2.
What NOT to Order Routinely
Testosterone testing is not indicated unless there are specific symptoms of hypogonadism (decreased libido, erectile dysfunction, fatigue) or physical examination findings suggesting androgen deficiency 8, 9. Free testosterone or androgen index is preferred over total testosterone if testing is warranted 9.
Clinical Context Matters
The extent of abnormality does not determine clinical significance 10. A mildly elevated ALT in the context of obesity may indicate NAFLD requiring intervention, while normal liver enzymes don't exclude significant fibrosis. Focus on the clinical context rather than the magnitude of derangement.
Male sex and elevated BMI are associated with higher odds of newly identified conditions, particularly hypertension and elevated cholesterol 4. If this patient has limited recent healthcare contact, the yield of screening increases substantially 4.
Common Pitfalls to Avoid
Don't repeat tests unnecessarily – If abnormalities are found, the strategy should be diagnostic workup, not simply repeating tests to see if they normalize 10
Don't order PSA without informed consent – This violates current guidelines and medicolegal standards 6, 7
Don't skip lipid screening – This has the highest therapeutic yield and is age-appropriate 3, 2
Don't assume normal tests exclude disease – Many chronic conditions (NAFLD, hepatitis C) present with normal or minimally abnormal laboratory values 10
Additional Screening Based on Risk Factors
If the patient has specific risk factors, add:
- Hepatitis C antibody if born between 1945-1965 or has risk factors
- HIV testing if sexually active or other risk factors present 11
- Hemoglobin A1c preferred over fasting glucose if compliance with fasting is uncertain 1
The decision to perform baseline tests should be influenced by risk factors, age, family history, and patient request, but 98% of family physicians perform baseline testing on healthy patients 12, reflecting real-world practice patterns despite limited guideline support for extensive testing in truly asymptomatic individuals.